Only 28% of #medtech companies have a clearly documented marketing strategy.
As our CEO, Saul W. Marquez, points out, that creates a significant opportunity. Being part of that 28% means your team is already ahead of many competitors, but the real advantage comes from turning that strategy into consistent, measurable action.
That clarity makes it easier to say yes to the right opportunities and no to the ones that do not support the bigger goal.
Watch the full video episode here:
As our CEO, Saul W. Marquez, points out, that creates a significant opportunity. Being part of that 28% means your team is already ahead of many competitors, but the real advantage comes from turning that strategy into consistent, measurable action.
That clarity makes it easier to say yes to the right opportunities and no to the ones that do not support the bigger goal.
Watch the full video episode here:
Shared byElliot Silva - 5 days ago
Log in to comment
Loading ..
Related Articles
GTM Ownership: Why Alignment Matters for HealthTech and MedTech Companies
Relevance Over Volume: Evolving B2B Email Strategies in Medtech
Understanding the Strategic Role of Public Relations in Business Success
Understanding AI's Role in GTM Strategy: Insights from B2B Marketing Report
Discover the 3D Growth Framework for Strategic Healthcare Marketing
CEO Saul Marquez Recaps DeviceTalks Boston 2026: Key Insights and Highlights
4
0/100